RS1 and retinoschisis: Importantly, Rs1-KO mouse models have served to show the possibility of gene therapy via intravitreal delivery of viral vectors carrying the normal gene, in preparation for application of this treatment in patients with retinoschisis (Byrne et al., 2014; Park et al., 2009; Zeng et al., 2004).